Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Optimising adalimumab treatment in psoriasis with concomitant methotrexate.

Trial Profile

Optimising adalimumab treatment in psoriasis with concomitant methotrexate.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2017

At a glance

  • Drugs Adalimumab (Primary) ; Methotrexate
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms OPTIMAP
  • Most Recent Events

    • 02 Feb 2017 New source identified and integrated (European Clinical Trials Database :EudraCT 2013-004918-18)
    • 02 Feb 2017 Trial design published in the Trials.
    • 02 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top